Your browser doesn't support javascript.
Alternative Management of Cushing's Syndrome During Covid-19 Pandemic
Coronaviruses ; 3(1):34-41, 2022.
Article in English | EMBASE | ID: covidwho-2255743
ABSTRACT
Cushing's syndrome results from prolonged exposure to glucocorticoids. Surgery is often the first-line treatment for this condition, regardless of etiology. However, the COVID-19 pandemic caused a decrease in surgical procedures due to the risk of infection transmission. There are still emergency cases of Cushing's syndrome that are admitted to the hospital and require urgent management. The current treatment should be focused on medical management and endovascular embolization in selective cases. Embolization can be performed in facilities where there aretrained personnel with experience in adrenal embolization. Surgery, which traditionally is a first-line therapy, can increase the risk of infection, therefore, it should be avoided. The current review provides a brief description of the possible options for the management of adrenal Cushing's syndrome during the COVID-19 pandemic.Copyright © 2022 Bentham Science Publishers.
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: Coronaviruses Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Language: English Journal: Coronaviruses Year: 2022 Document Type: Article